The lawsuit filed in Maricopa County Superior Court contends GlaxoSmithKline's actions violate the Arizona Consumer Fraud Act ...

PHOENIX — Arizona is suing a major drug maker, accusing it of gaming the system by simply renaming an asthma drug to allow it ...

GSK (LON:GSK) has raised its long-term revenue outlook, now expecting sales to exceed 40 billion by 2031, up from 38 billion.

GSK Plc plans to buy back £2 billion ($2.5 billion) of shares as it raised its long-term growth outlook on optimism around ...

European markets opened mixed on Wednesday, with investors looking ahead to more earnings from a number of key companies.

GSK and the University of Oxford have joined hands to focus on the potential of cancer prevention through vaccination. The ...

GSK plc (LSE/NYSE: GSK), a prominent pharmaceutical company with a market capitalization of $71.29 billion and currently ...

The age of targeted cancer therapies brings the potential for more treatment options, greater effectiveness and fewer side effects.

Personalized medicine is a therapeutic approach involving the use of an individual’s genetic and epigenetic information to tailor drug therapy or preventive care. Two-step Mendelian ...

If your symptoms are serious or your doctor thinks something else is causing them, they might recommend a prescription medicine. Most people don't need any kind of treatment for mild cold symptoms.

Depemokimab data reveals 72% reduction in hospitalizations; projected sales hit £4 billion. GSK plc GSK expects strong momentum in the specialty business segment to continue with growth from ...

Following GSK’s deal-heavy end to 2024, Chief Scientific Officer Tony Wood, Ph.D., doesn’t expect the trend to let up in the new year, zeroing in on partnerships that can expand knowledge ...